Grant/GrossMendelsohn »

Immunitybio shares owned by Grant/GrossMendelsohn

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Grant/GrossMendelsohn from 13F filings

Historical chart of Grant/GrossMendelsohn investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Grant/GrossMendelsohn consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Grant/GrossMendelsohn

Quarter filed Position value Share count Share price at filing
2025-03-31 $40k 15k 2.63

More positions owned by Grant/GrossMendelsohn

Ishares Tr TRS FLT RT BD (TFLO)
Spdr Gold Tr Gold Shs (GLD)
T Rowe Price Etf Cap Appreciation (TCAF)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Oracle Corporation (ORCL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Fidelity Covington Trust Msci Utils Index (FUTY)
Apple (AAPL)
Fidelity Covington Trust Consmr Staples (FSTA)
Fidelity Covington Trust Msci Hlth Care I (FHLC)
Microsoft Corporation (MSFT)

View all positions for Grant/GrossMendelsohn

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio